Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$1.01 - $1.25 $10,302 - $12,750
-10,200 Reduced 49.35%
10,470 $11,000
Q1 2023

May 16, 2023

SELL
$0.82 - $1.32 $217 - $349
-265 Reduced 1.27%
20,670 $20,000
Q4 2022

Feb 14, 2023

BUY
$0.64 - $1.31 $13,398 - $27,424
20,935 New
20,935 $18,000
Q2 2022

Aug 15, 2022

SELL
$0.56 - $3.25 $1,737 - $10,081
-3,102 Reduced 19.13%
13,110 $11,000
Q4 2021

Feb 14, 2022

BUY
$4.26 - $23.33 $69,063 - $378,225
16,212 New
16,212 $83,000

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $55.6M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.